vs

Side-by-side financial comparison of Cognizant (CTSH) and Emerson Electric (EMR). Click either name above to swap in a different company.

Cognizant is the larger business by last-quarter revenue ($5.4B vs $4.3B, roughly 1.2× Emerson Electric). Emerson Electric runs the higher net margin — 13.9% vs 12.2%, a 1.7% gap on every dollar of revenue. On growth, Cognizant posted the faster year-over-year revenue change (5.8% vs 4.1%). Emerson Electric produced more free cash flow last quarter ($602.0M vs $198.0M). Over the past eight quarters, Cognizant's revenue compounded faster (5.6% CAGR vs -0.3%).

Cognizant Technology Solutions Corporation is an American multinational information technology consulting and outsourcing company originally founded in India. It is headquartered in Teaneck, New Jersey, United States. Cognizant is part of the NASDAQ-100 and trades under CTSH. It was founded in Chennai, India, as an in-house technology unit of Dun & Bradstreet in 1994, and started serving external clients in 1996.

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

CTSH vs EMR — Head-to-Head

Bigger by revenue
CTSH
CTSH
1.2× larger
CTSH
$5.4B
$4.3B
EMR
Growing faster (revenue YoY)
CTSH
CTSH
+1.7% gap
CTSH
5.8%
4.1%
EMR
Higher net margin
EMR
EMR
1.7% more per $
EMR
13.9%
12.2%
CTSH
More free cash flow
EMR
EMR
$404.0M more FCF
EMR
$602.0M
$198.0M
CTSH
Faster 2-yr revenue CAGR
CTSH
CTSH
Annualised
CTSH
5.6%
-0.3%
EMR

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CTSH
CTSH
EMR
EMR
Revenue
$5.4B
$4.3B
Net Profit
$662.0M
$605.0M
Gross Margin
53.2%
Operating Margin
15.6%
17.8%
Net Margin
12.2%
13.9%
Revenue YoY
5.8%
4.1%
Net Profit YoY
-0.2%
3.4%
EPS (diluted)
$1.39
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTSH
CTSH
EMR
EMR
Q1 26
$5.4B
Q4 25
$5.3B
$4.3B
Q3 25
$5.4B
$4.9B
Q2 25
$5.2B
$4.6B
Q1 25
$5.1B
$4.4B
Q4 24
$5.1B
$4.2B
Q3 24
$5.0B
$4.6B
Q2 24
$4.8B
$4.4B
Net Profit
CTSH
CTSH
EMR
EMR
Q1 26
$662.0M
Q4 25
$648.0M
$605.0M
Q3 25
$274.0M
$637.0M
Q2 25
$645.0M
$586.0M
Q1 25
$663.0M
$485.0M
Q4 24
$546.0M
$585.0M
Q3 24
$582.0M
$996.0M
Q2 24
$566.0M
$329.0M
Gross Margin
CTSH
CTSH
EMR
EMR
Q1 26
Q4 25
53.2%
Q3 25
51.9%
Q2 25
52.6%
Q1 25
53.5%
Q4 24
53.5%
Q3 24
51.3%
Q2 24
52.8%
Operating Margin
CTSH
CTSH
EMR
EMR
Q1 26
15.6%
Q4 25
16.0%
17.8%
Q3 25
16.0%
16.4%
Q2 25
15.6%
16.1%
Q1 25
16.7%
14.2%
Q4 24
14.8%
18.6%
Q3 24
14.6%
14.7%
Q2 24
14.6%
10.4%
Net Margin
CTSH
CTSH
EMR
EMR
Q1 26
12.2%
Q4 25
12.2%
13.9%
Q3 25
5.1%
13.1%
Q2 25
12.3%
12.9%
Q1 25
13.0%
10.9%
Q4 24
10.7%
14.0%
Q3 24
11.5%
21.6%
Q2 24
11.7%
7.5%
EPS (diluted)
CTSH
CTSH
EMR
EMR
Q1 26
$1.39
Q4 25
$1.35
$1.07
Q3 25
$0.56
$1.12
Q2 25
$1.31
$1.04
Q1 25
$1.34
$0.86
Q4 24
$1.10
$1.02
Q3 24
$1.17
$1.74
Q2 24
$1.14
$0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTSH
CTSH
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$1.5B
Total DebtLower is stronger
$568.0M
$7.6B
Stockholders' EquityBook value
$15.1B
$20.3B
Total Assets
$20.5B
$41.9B
Debt / EquityLower = less leverage
0.04×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTSH
CTSH
EMR
EMR
Q1 26
$1.5B
Q4 25
$1.9B
Q3 25
$2.4B
Q2 25
$1.8B
Q1 25
$2.0B
Q4 24
$2.2B
Q3 24
$2.0B
Q2 24
$2.2B
Total Debt
CTSH
CTSH
EMR
EMR
Q1 26
$568.0M
Q4 25
$7.6B
Q3 25
$8.9B
Q2 25
$8.3B
Q1 25
$8.2B
Q4 24
$6.6B
Q3 24
$7.7B
Q2 24
$7.1B
Stockholders' Equity
CTSH
CTSH
EMR
EMR
Q1 26
$15.1B
Q4 25
$15.0B
$20.3B
Q3 25
$14.9B
$20.3B
Q2 25
$15.3B
$19.9B
Q1 25
$14.9B
$19.2B
Q4 24
$14.4B
$20.5B
Q3 24
$14.5B
$21.6B
Q2 24
$13.9B
$20.8B
Total Assets
CTSH
CTSH
EMR
EMR
Q1 26
$20.5B
Q4 25
$20.7B
$41.9B
Q3 25
$20.1B
$42.0B
Q2 25
$20.2B
$42.5B
Q1 25
$20.0B
$42.0B
Q4 24
$20.0B
$42.6B
Q3 24
$20.2B
$44.2B
Q2 24
$18.6B
$45.6B
Debt / Equity
CTSH
CTSH
EMR
EMR
Q1 26
0.04×
Q4 25
0.37×
Q3 25
0.44×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.32×
Q3 24
0.36×
Q2 24
0.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTSH
CTSH
EMR
EMR
Operating Cash FlowLast quarter
$274.0M
$699.0M
Free Cash FlowOCF − Capex
$198.0M
$602.0M
FCF MarginFCF / Revenue
3.7%
13.9%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
0.41×
1.16×
TTM Free Cash FlowTrailing 4 quarters
$2.5B
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTSH
CTSH
EMR
EMR
Q1 26
$274.0M
Q4 25
$858.0M
$699.0M
Q3 25
$1.2B
$3.1B
Q2 25
$398.0M
$1.1B
Q1 25
$400.0M
$241.0M
Q4 24
$920.0M
$777.0M
Q3 24
$847.0M
$3.3B
Q2 24
$262.0M
$1.1B
Free Cash Flow
CTSH
CTSH
EMR
EMR
Q1 26
$198.0M
Q4 25
$781.0M
$602.0M
Q3 25
$1.2B
$2.7B
Q2 25
$331.0M
$977.0M
Q1 25
$323.0M
$154.0M
Q4 24
$837.0M
$694.0M
Q3 24
$791.0M
$2.9B
Q2 24
$183.0M
$998.0M
FCF Margin
CTSH
CTSH
EMR
EMR
Q1 26
3.7%
Q4 25
14.6%
13.9%
Q3 25
21.4%
54.9%
Q2 25
6.3%
21.5%
Q1 25
6.3%
3.5%
Q4 24
16.5%
16.6%
Q3 24
15.7%
63.1%
Q2 24
3.8%
22.8%
Capex Intensity
CTSH
CTSH
EMR
EMR
Q1 26
Q4 25
1.4%
2.2%
Q3 25
1.2%
8.9%
Q2 25
1.3%
2.0%
Q1 25
1.5%
2.0%
Q4 24
1.6%
2.0%
Q3 24
1.1%
9.1%
Q2 24
1.6%
2.1%
Cash Conversion
CTSH
CTSH
EMR
EMR
Q1 26
0.41×
Q4 25
1.32×
1.16×
Q3 25
4.48×
4.86×
Q2 25
0.62×
1.83×
Q1 25
0.60×
0.50×
Q4 24
1.68×
1.33×
Q3 24
1.46×
3.35×
Q2 24
0.46×
3.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTSH
CTSH

Segment breakdown not available.

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

Related Comparisons